Oskar Eriksson
- E-post:
- oskar.eriksson@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
MD, PhD
Docent i experimentell klinisk immunologi
ST-läkare i klinisk immunologi och transfusionsmedicin
Biografi
2013 Läkarexamen Uppsala universitet
2015 Doktorsexamen Uppsala universitet
2016-2018 Post doc finansierad av Vetenskapsrådet, Harvard Medical School, Boston, USA
2019-2022 AT-läkare, Akademiska sjukhuset
2022- ST-läkare, Klinisk immunologi och transfusionsmedicin, Akademiska sjukhuset
2022 Docent i experimentell klinisk immunologi
Publikationer
Senaste publikationer
- A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile (2024)
- Combined Heterozygous Genetic Variations in Complement C2 and C8B (2023)
- Complement and platelets (2023)
- How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system (2023)
- Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19 (2022)
Alla publikationer
Artiklar
- A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile (2024)
- Combined Heterozygous Genetic Variations in Complement C2 and C8B (2023)
- Complement and platelets (2023)
- How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system (2023)
- Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19 (2022)
- Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis-A Swedish biobank study (2022)
- Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients. (2022)
- How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment (2022)
- The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System (2021)
- Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients (2020)
- Blood type A associates with critical COVID-19 and death in a Swedish cohort (2020)
- The Human Platelet as an Innate Immune Cell (2019)
- Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics (2019)
- First-in-class PET tracer for the glucagon receptor (2017)
- A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression (2016)
- Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer (2016)
- Tissue Factor Noncoagulant Signaling (2015)
- Neutrophil CD64 expression - comparison of two different flow cytometry protocols on EPICs MCL and the Leuko64 (TM) assay on a Celldyn Sapphire haematology analyser (2015)
- Cross-talk between tissue factor and EPHA2 in cancer (2015)
- The Eph Tyrosine Kinase Receptors EphB2 and EphA2 Are Novel Proteolytic Substrates of Tissue Factor/Coagulation Factor VIIa (2014)
- Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor (2014)
- The insulin-like growth factor 1 receptor mediates tissue factor/FVIIa-induced cell survival (2013)
Böcker
